BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11122547)

  • 1. Ticlopidine and aspirin fail to suppress the increased platelet aggregability that follows percutaneous coronary interventions.
    Fischetti D; Sciahbasi A; Leone AM; Niccoli G; Schiavoni G; Trani C; Mazzari MA; Andreotti F
    J Thromb Thrombolysis; 2000 Dec; 10(3):265-9. PubMed ID: 11122547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of platelet inhibition of ticlopidine plus aspirin vs aspirin alone given prior to elective PTCA.
    van de Loo A; Nauck M; Noory E; Just H; Wollschläger H
    Eur Heart J; 1998 Jan; 19(1):96-102. PubMed ID: 9503181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of antiplatelet drugs, heparin, and preanalytical variables on platelet function detected by the platelet function analyzer (PFA-100).
    Kottke-Marchant K; Powers JB; Brooks L; Kundu S; Christie DJ
    Clin Appl Thromb Hemost; 1999 Apr; 5(2):122-30. PubMed ID: 10725993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antiplatelet effect of loading dose of clopidogrel versus abciximab during coronary intervention.
    Claeys MJ; Van Der Planken MG; Michiels JJ; Vertessen F; Dilling D; Bosmans JM; Vrints CJ
    Blood Coagul Fibrinolysis; 2002 Jun; 13(4):283-8. PubMed ID: 12032392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilation procedures.
    Gregorini L; Marco J; Fajadet J; Bernies M; Cassagneau B; Brunel P; Bossi IM; Mannucci PM
    J Am Coll Cardiol; 1997 Jan; 29(1):13-20. PubMed ID: 8996289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of plasma fibrinogen concentration on the inhibition of platelet aggregation after ticlopidine compared with aspirin.
    Tohgi H; Takahashi H; Kashiwaya M; Watanabe K
    Stroke; 1994 Oct; 25(10):2017-21. PubMed ID: 8091447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Whole Blood Platelet Aggregation at Baseline and in Response to Aspirin and Aspirin Plus Clopidogrel in Patients With Versus Without Chronic Kidney Disease.
    Jain N; Li X; Adams-Huet B; Sarode R; Toto RD; Banerjee S; Hedayati SS
    Am J Cardiol; 2016 Feb; 117(4):656-663. PubMed ID: 26725101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiplatelet effects of combined therapy with ticlopidine and low doses of aspirin on patients with ischemic cardiopathy].
    Davì G; Catalano I; Spatola A; Alaimo P; Notarbartolo A; Cerbone AM; Strano A
    Cardiologia; 1989 Jan; 34(1):69-71. PubMed ID: 2720715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor.
    Hansson EC; Shams Hakimi C; Åström-Olsson K; Hesse C; Wallén H; Dellborg M; Albertsson P; Jeppsson A
    Br J Anaesth; 2014 Mar; 112(3):570-5. PubMed ID: 24148324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of diltiazem on platelet activation and cytosolic calcium during percutaneous transluminal coronary angioplasty.
    Dai H; Chen J; Tao Q; Zhu J; Zhang F; Zheng L; Qiu Y
    Postgrad Med J; 2003 Sep; 79(935):522-6. PubMed ID: 13679549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
    Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
    Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-grade exercise enhances platelet aggregability in patients with obstructive coronary disease independently of myocardial ischemia.
    Andreotti F; Lanza GA; Sciahbasi A; Fischetti D; Sestito A; De Cristofaro R; Maseri A
    Am J Cardiol; 2001 Jan; 87(1):16-20. PubMed ID: 11137827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet aggregability and occurrence of restenosis following coronary angioplasty.
    Goel PK; Shahi M; Agarwal AK; Srivastava S; Seth PK
    Int J Cardiol; 1997 Aug; 60(3):227-31. PubMed ID: 9261632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions.
    Lepäntalo A; Virtanen KS; Heikkilä J; Wartiovaara U; Lassila R
    Eur Heart J; 2004 Mar; 25(6):476-83. PubMed ID: 15039127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid assessment of glycoprotein IIb/IIIa blockade with the platelet function analyzer (PFA-100) during percutaneous coronary intervention.
    Madan M; Berkowitz SD; Christie DJ; Jennings LK; Smit AC; Sigmon KN; Glazer S; Tcheng JE
    Am Heart J; 2001 Feb; 141(2):226-33. PubMed ID: 11174336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
    Lev EI; Patel RT; Maresh KJ; Guthikonda S; Granada J; DeLao T; Bray PF; Kleiman NS
    J Am Coll Cardiol; 2006 Jan; 47(1):27-33. PubMed ID: 16386660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation.
    Rupprecht HJ; Darius H; Borkowski U; Voigtländer T; Nowak B; Genth S; Meyer J
    Circulation; 1998 Mar; 97(11):1046-52. PubMed ID: 9531251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lack of augmentation by aspirin of inhibition of platelet reactivity by ticlopidine.
    Farrell TP; Hayes KB; Sobel BE; Schneider DJ
    Am J Cardiol; 1999 Mar; 83(5):770-4. PubMed ID: 10080435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting.
    Kopp CW; Steiner S; Priglinger U; Christ G; Probst P; Maurer G; Minar E; Huber K
    Blood Coagul Fibrinolysis; 2003 Jun; 14(4):379-86. PubMed ID: 12945880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization.
    Gao P; Xiong H; Zheng Z; Li L; Gao R; Hu SS
    Platelets; 2010; 21(3):183-90. PubMed ID: 20201634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.